Elissa Slotkin urges HHS to release Title X funding as March 31 deadline nears
U. S. Senator elissa slotkin joined 38 colleagues in a letter to Health and Human Services Secretary Robert F. Kennedy Jr., calling for immediate action on Title X funding. The request highlights a documented gap between the senators’ demand for uninterrupted access and the program’s pending March 31, 2026 funding lapse, after a prior period in which funding was withheld for months and later restored.
Elissa Slotkin letter to Robert F. Kennedy Jr. seeks a one-year extension
The confirmed action in the record is a joint letter signed by Senator Elissa Slotkin (D-MI) and 38 other senators, sent to HHS Secretary Robert F. Kennedy Jr. The letter demands that HHS award a one-year full funding extension for all current Title X grantees, framed as necessary to protect Americans’ uninterrupted access to comprehensive family planning and related services.
The context states that Title X grantees’ current funding is set to lapse on March 31, 2026. The letter’s central request is not described as a new program or an expansion; it is described as a full funding extension for existing grantees. That specificity matters because it narrows the dispute to timing and continuity rather than eligibility changes or new requirements. Still, the context does not confirm when the letter was sent or whether HHS has responded.
The letter also lays out what Title X covers. The context describes Title X services as including contraception, cervical cancer screenings, pregnancy testing and counseling, and sexually transmitted infection testing and treatment. It also states that since 1970, the Title X Family Planning Program has provided family planning and preventive health services for low-income or uninsured patients.
March 31, 2026 lapse follows earlier Title X delays under the Trump Administration
The tension driving the current demand is anchored in a prior episode described in the context: last year, the Trump Administration withheld millions in funding from almost one in five Title X grantees for months. The context ties that withholding to concrete effects, stating it placed over 840, 000 people at risk of losing access to Title X-funded care and forced some sites to close.
Yet the same context says the administration restored funding to these groups by December 2025, while also noting that many grantees were forced to serve the same need with reduced funding. Read together, those facts outline a pattern of disruption followed by partial recovery: funding returned, but after months of strain and amid reduced resources for providers expected to meet the same demand.
What remains unclear is what mechanism caused the earlier withholding, what criteria determined which grantees were affected, and how the restored funding compared to prior levels for each organization. The context does not confirm whether the same dynamics are at play in the upcoming March 31, 2026 lapse, or whether the lapse is a routine end-of-cycle deadline that requires administrative renewal.
Title X outcomes cited by senators, but decision-making timeline remains unconfirmed
The letter’s argument links Title X to broad public health outcomes. Senators highlight Title X as helping provide broader access to services that have resulted in improved health outcomes, including lower maternal and infant mortality, fewer premature births, and lower rates of cancer. Those claims, as presented in the context, function as the justification for urgency: disruption to the funding stream is framed as a threat not only to clinic operations, but also to health outcomes that the program is described as supporting.
The signatories listed in the context include Senator Gary Peters (D-MI) as well as Senators Mazie K. Hirono (D-HI), Patty Murray (D-WA), Angus King (I-ME), and many others, totaling 39 senators including Senator Slotkin. That breadth signals coordinated pressure within the Senate. At the same time, the context does not confirm any next procedural step by HHS, any commitment to release funds, or any deadline set by HHS for decisions before March 31, 2026.
For now, the verified facts leave two parallel tracks: the senators’ stated goal of uninterrupted access, and a calendar reality that current funding is set to lapse. If HHS confirms a one-year full funding extension for all current Title X grantees before March 31, 2026, it would establish that the department acted to prevent the type of service disruption described in the context during the earlier months-long withholding period.
